Pavilion Capital

Founded in 2011 and headquartered in Singapore, Pavilion Capital is a private equity firm that invests primarily in privately owned businesses across North Asia.

Roland Ang

Fund Manager

Danny Wong

Head of North Asia

88 past transactions

Eclypsium

Series C in 2025
Eclypsium develops a cloud-based platform that secures the unprotected firmware and hardware layer of enterprises. Its solution safeguards laptops, servers, and networking infrastructure against threats originating below the operating system.

NetraDyne

Series D in 2025
NetraDyne Inc. is a technology company that specializes in artificial intelligence-based fleet management solutions aimed at enhancing safety and performance in the transportation industry. Founded in 2015 and headquartered in San Diego, California, with an additional office in Bengaluru, India, the company develops an Internet of Things platform that processes visual and sensory inputs. Its flagship products include VisionPRO, an integrated safety system that captures and analyzes driving events through multiple camera angles, and Driveri, which focuses on recognizing and rewarding positive driver behavior. By leveraging advancements in camera technology, deep learning, and data analysis, NetraDyne aims to reduce accidents and improve fleet management, ultimately establishing a new standard for safe driving practices in commercial vehicles.

Asuene

Series C in 2024
Asuene provides renewable power retail services for local production and consumption and develops a carbon management platform that enables organizations to track, manage, and report greenhouse gas emissions. The platform integrates data from multiple sources using artificial intelligence to create strategies for reducing pollutants, improving environmental performance, complying with regulations, and advancing sustainability goals.

Rebellions

Series B in 2024
Rebellions.ai is a developer of artificial intelligence semiconductor-based solutions focused on creating AI accelerators that connect core semiconductor architectures with deep learning algorithms. The company aims to deliver domain-specific AI processors alongside optimized software, effectively bridging the gap between silicon technology and advanced AI applications. By re-architecting AI processors to integrate specialized deep learning kernels, Rebellions enables clients to utilize energy-efficient AI hardware that seamlessly integrates into their operations. This approach allows clients to maximize the potential of their silicon resources while enhancing performance in AI-driven tasks.

Etaily

Series A in 2023
Etaily develops an e-commerce enablement platform that assists clients in managing varied brands. The platform offers services including warehousing, fulfillment, digital channel integration, channel management, performance marketing, and social media marketing. This allows clients to scale their businesses by leveraging Etaily's technology, operations, brand-building expertise, and fulfillment ecosystem.

EcoSpirits

Venture Round in 2023
EcoSpirits is a company focused on creating a closed-loop distribution system aimed at minimizing packaging waste within the premium spirits supply chain. It has developed innovative technology that includes a fully reusable, tamper-proof, and shock-proof glass vessel, alongside a semi-automated facility for sanitizing, refilling, and sealing spirits. This approach not only significantly reduces packaging and transport costs for businesses but also leads to a substantial reduction in carbon footprints. By streamlining the distribution process, EcoSpirits offers a sustainable alternative that benefits both the environment and the bottom line.

Accredify

Series A in 2023
Accredify is a Singapore-based company specializing in the creation and issuance of verifiable digital documents for organizations across various sectors. With a presence in over nine markets and a client base of 900 globally, Accredify has facilitated nearly 7 million verifications of its documents. The company's cloud-based system ensures that all issued documents are tamper-proof and traceable, allowing users to verify them through a simple drag-and-drop process. Initially focused on the higher education sector, Accredify has since expanded into healthcare, notably contributing to the development of Singapore's HealthCerts, which provide digitally verifiable COVID-19 test results. Recognized internationally, these certificates can be validated via QR codes and are accepted in over 32 countries. Accredify also offers a suite of APIs for seamless integration, enabling organizations to automate the issuance of verifiable digital credentials. With a commitment to customer service, security, and legal compliance, Accredify aims to be a trusted solution for document management and verification.

Travelio

Series C in 2023
Travelio is an online marketplace for short-term home rentals, offering a diverse range of accommodations, including apartments, villas, and houses. Founded on March 24, 2015, by Christine Amanda, Christina Suriadjaja, and Hendry Rusli, the platform simplifies the property rental process for both renters and property owners. It enables clients to easily reserve and select their desired accommodations online while providing property owners and developers with tools to lease and manage their vacant properties effectively. Travelio aims to enhance the rental experience by connecting travelers with suitable housing options.

Medigo

Series A in 2023
Medigo is a Berlin-based company that operates a platform to simplify international medical travel by connecting patients with clinics. The platform functions as a clinic marketplace, allowing users to search, compare, and coordinate procedures, browse clinics by procedure or country, filter by facility type, and obtain cost and treatment information. Beyond the marketplace, Medigo provides global healthcare access through a third-party administrator model that helps organizations manage international care with an international provider network, cost containment tools, and a focus on member experience. Additional services include claims handling, medical concierge, and network access to assist insurers in delivering care abroad and achieving potential savings, all aimed at improving the patient journey across borders.

Quqo

Seed Round in 2022
Quqo is a digital distribution platform based in Bogotá, Colombia, founded in 2019. It connects suppliers, manufacturers, and local retailers, primarily in the fast-moving consumer goods sector. The company's platform streamlines the procurement process, facilitating an online marketplace that enhances the efficiency of supply chains for both small and large retailers. Quqo offers a range of services, including sales force automation, distribution management systems, and business intelligence tools, along with payment options like e-wallets and buy-now-pay-later financing. By optimizing these processes, Quqo aims to ensure profitability for all participants in the supply chain while enabling micro, small, and medium businesses to provide a diverse range of grocery products to consumers.

JNPMEDI

Series A in 2022
JNPMEDI develops a medical data platform for conducting clinical research and managing trials. It specializes in digital transformation tools for regulatory authorities, pharmaceuticals, and clinical research organizations.

Vow

Series A in 2022
Vow Foods is a company that specializes in producing cultivated exotic meat through lab-based methods. By utilizing animal cells rather than traditional livestock, Vow aims to create sustainable and ethical meat alternatives. The process involves harvesting animal cells via biopsy and growing them in a nutrient-rich medium, which allows for the development of a diverse range of meat products. This innovative approach not only provides consumers, restaurants, and chefs with nutritious and flavorful options but also reduces reliance on natural resources typically used in conventional meat production.

Starfire Energy

Series B in 2022
Starfire Energy is a company focused on developing and deploying sustainable energy technologies, specializing in the production of carbon-free ammonia. Founded in 2007 and headquartered in Aurora, Colorado, Starfire Energy has created modular systems that synthesize ammonia from renewable energy sources, specifically wind and solar power. These modular plants are built in shipping containers that are pre-wired and pre-plumbed, facilitating easy on-site installation. The ammonia produced is not only used as a fertilizer and refrigerant but also serves as an energy-dense liquid fuel. By utilizing renewable energy, air, and water as inputs, Starfire Energy aims to meet the growing demands for energy storage and transportation while contributing to carbon-free industrial processes.

LevitasBio

Series C in 2022
LevitasBio specializes in cellular analytics through its innovative platform that employs magnetic levitation technology. This approach addresses the limitations of traditional cellular analysis by offering label-free and universal methods for studying high-value primary samples and sensitive cell types. The company's LeviCell platform enables scientists to purify cells and nuclei without the need for markers or modifications, allowing for the examination of biological signatures while preserving the integrity of the original samples. By facilitating a deeper and more accurate understanding of biological processes, LevitasBio aims to advance research in the life sciences and healthcare sectors.

Partipost

Series B in 2022
Partipost operates a crowd influencer marketing and commerce platform that connects brands with influencers across all follower tiers to drive authentic word-of-mouth advertising. The platform uses data insights from in-app polls and user behavior to identify influencers with strong brand affinity and crowdsources creators ranging from a few hundred to millions of followers. It enables brands to organize influencer campaigns and lets everyday people earn by promoting products within their communities, supported by an automated system that streamlines campaign management and measurement.

Structo

Venture Round in 2022
Structo is a digital manufacturing platform specializing in dental 3D printing services. The company has developed a range of application-specific 3D printing resins that complement its proprietary hardware technology. By focusing on enhancing the speed and efficiency of 3D printing, Structo enables users to achieve higher throughput at lower costs compared to traditional stereolithography (SLA) printers. Their innovative approach allows dental professionals to revolutionize their business models while maintaining high print quality.

Asuene

Series B in 2022
Asuene provides renewable power retail services for local production and consumption and develops a carbon management platform that enables organizations to track, manage, and report greenhouse gas emissions. The platform integrates data from multiple sources using artificial intelligence to create strategies for reducing pollutants, improving environmental performance, complying with regulations, and advancing sustainability goals.

Zilliz

Series B in 2022
Founded in 2016, Zilliz specializes in developing advanced vector database technologies. Headquartered in San Francisco, the company empowers organizations worldwide to create AI/ML applications by simplifying complex data infrastructure management.

Insilico Medicine

Series D in 2022
Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

MOON-X

Series B in 2022
Founded in Tokyo, Japan in 2019, MOON-X is a consumer goods manufacturer that enriches lives through co-creation with communities and manufacturing partners. Its product portfolio spans craft beer, men's skincare products, women's skincare products, baby and maternity items, leather accessories, and business goods.

Rebellions

Series A in 2022
Rebellions.ai is a developer of artificial intelligence semiconductor-based solutions focused on creating AI accelerators that connect core semiconductor architectures with deep learning algorithms. The company aims to deliver domain-specific AI processors alongside optimized software, effectively bridging the gap between silicon technology and advanced AI applications. By re-architecting AI processors to integrate specialized deep learning kernels, Rebellions enables clients to utilize energy-efficient AI hardware that seamlessly integrates into their operations. This approach allows clients to maximize the potential of their silicon resources while enhancing performance in AI-driven tasks.

Megarobo

Series C in 2022
Megarobo is an AI and robotics company established in 2016 and headquartered in Beijing, China. It specializes in developing collaborative robots and advanced automation solutions tailored for life sciences, clinical diagnosis, and applied chemistry. By focusing on integrating robotics and artificial intelligence into industry applications, Megarobo aims to enhance research efficiency for life science companies and scientific research institutions. The company is dedicated to providing flexible and practical automation products that streamline laboratory services, ultimately driving innovation in the field of scientific research.

Insilico Medicine

Series D in 2022
Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

RVAC Medicines

Series B in 2022
Founded in Singapore in 2021, RVAC Medicines is a biotechnology company specializing in the development of novel mRNA vaccines and therapeutics. It focuses on addressing unmet medical needs, particularly in emerging markets, through its cutting-edge GMP manufacturing facilities and platform technologies.

Swatch On

Venture Round in 2022
Swatch On operates a fabric marketplace designed to facilitate reliable fabric sourcing for fashion designers. Launched with the goal of offering a diverse selection of unique, high-quality wholesale fabrics at competitive prices, Swatch On has developed a comprehensive database of fabrics sourced from Dongdaemun. The company prides itself on its team of young, creative, and motivated professionals who are passionate about fashion fabric. Their personalized approach ensures that clients receive tailored assistance in finding the perfect materials for their collections, enhancing the overall experience of sourcing fabrics for design projects.

ENSEM Therapeutics

Series A in 2022
ENSEM Therapeutics is a pioneering drug discovery and development company focused on creating innovative small-molecule precision medicines for oncology. Utilizing its proprietary Kinetic Ensemble platform, the company specializes in detecting and characterizing rare conformational states of drug targets, which are crucial for understanding oncogenic processes, regulatory mechanisms, and drug resistance. This approach not only provides new therapeutic opportunities but also allows drug developers to address high-value targets that are typically challenging to target. With potential applications extending beyond oncology to genetic disorders and other disease areas, ENSEM Therapeutics aims to transform the landscape of precision medicine.

Med247

Series A in 2022
Med247 is an offline-to-online healthcare platform that enables users to book appointments and consult with professional doctors online. It aims to become a standardized platform connecting various healthcare service providers.

Ark Edge Space

Series A in 2022
ArkEdge Space is a manufacturer of microsatellites aimed at promoting space development and usage. The company develops and tests an ultra-small spacecraft that is responsible for communication and positioning systems for lunar activities, as well as establishes a method for cost reduction and mass production of high-performance 6U satellites, allowing businesses in positioning and communication technology to benefit the community by meeting their space needs.

Synspective

Series B in 2022
Synspective specializes in developing and operating small synthetic aperture radar (SAR) satellites, providing SAR data and remote monitoring services. It caters to urban design, infrastructure, energy, insurance, finance sectors, and government agencies.

SemiFive

Series B in 2022
SemiFive is a processor design company based in Seongnam-si, South Korea, specializing in custom silicon solutions. It develops RISC-V core intellectual property and cloud-based SoC design platforms to create custom systems for consumer and industrial IoT. The company offers end-to-end SoC design capabilities, including platform-based approaches that leverage configurable domain-specific architectures and pre-validated IP pools to accelerate development and reduce cost and risk. It collaborates with foundry partners, notably Samsung Foundry as a SAFETM DSP partner, to provide a one-stop solution for silicon designs. SemiFive aims to help customers realize AI-enabled and data-center oriented workloads through scalable, low-cost silicon solutions.

GrowSari

Series C in 2022
GrowSari is a technology-driven B2B platform designed to empower sari-sari stores by transforming them from basic fast-moving consumer goods (FMCG) outlets into comprehensive service hubs. The company provides shop owners with the necessary tools and infrastructure to digitally procure goods, thereby eliminating the need for middlemen. Through its e-commerce marketplace, GrowSari connects stores directly to suppliers, enabling owners to expand their product offerings to include mobile top-ups, remittances, and banking services. This approach not only helps store owners reduce costs but also enhances their understanding of market trends, ultimately benefiting grassroots communities across the nation.

Rokt

Series E in 2021
Rokt is a software company that provides e-commerce technology and marketing solutions designed to weave native advertising into shoppers' transactional flows. By connecting advertisers with customers at the moment of purchase, it places relevant messages within checkout and related steps, helping e-commerce operators increase revenue, improve the customer experience, and support cross-selling and upsell opportunities.

UrBox

Series A in 2021
UrBox is Vietnam's leading electronic gift company, digitizing gifts through its platform UrBox.vn. With over 3000 partners, it serves large customers across various industries by streamlining marketing programs, reducing costs and resources.

Space BD

Venture Round in 2021
Space BD is a provider of space-related services that focuses on facilitating the industrialization of space. The company aims to serve as a comprehensive resource for businesses developing new technologies, helping them navigate challenges in the commercialization of low Earth orbit. By adopting a business-driven approach, Space BD seeks to simplify access to space for scientists and organizations, thereby promoting innovation and growth in the space sector.

HotSpot Therapeutics

Series C in 2021
HotSpot Therapeutics is a biotechnology startup based in Boston, Massachusetts, established in 2017. The company specializes in the development of allosteric therapies that target regulatory sites on proteins. Its innovative therapeutic platform is designed to identify hotspots and locate pathway treatments for cancer, metabolic disorders, and rare diseases. By leveraging a comprehensive database of hotspot structures and utilizing data science, HotSpot Therapeutics employs a multidisciplinary approach to drug discovery. This approach aims to enhance the effectiveness of treatments and improve patient outcomes across a range of conditions.

Hepmil

Series A in 2021
Hepmil Media Group is a technology-driven media company based in Southeast Asia that focuses on enhancing the lives of millions through engaging and entertaining content. It operates a media service platform designed to connect internet influencers with corporate clients. By partnering with content creators who possess substantial followings on various content-sharing platforms, Hepmil facilitates marketing activities that leverage the influence of these internet celebrities. The company offers localization and strategic direction to brands, ensuring effective collaboration between influencers and corporate partners. Through its innovative approach, Hepmil aims to create meaningful connections that benefit both content creators and businesses.

Linc'well

Series C in 2021
Linc'well Inc., founded in 2018 and based in Tokyo, Japan, is a healthcare technology company that develops a software as a service (SaaS) platform tailored for the healthcare industry. The platform offers various digital services including web inquiries, call handling, payment processing, electronic medical records management, and other digitization solutions. Additionally, Linc'well provides clinic operation and management support through its brand CLINIC FORE, along with online support services such as medical supplement subscriptions. These offerings are designed to enhance the efficiency of healthcare institutions and clinics by improving operational processes and patient experiences.

Infinium

Venture Round in 2021
Infinium produces synthetic fuels from renewable energy and waste carbon dioxide, offering a lower-carbon alternative for transportation systems and chemical processes like plastics production.

Infostellar

Series B in 2021
Infostellar Inc. is a Tokyo-based company founded in 2016 that specializes in developing modular software systems for satellite communication. Its primary offering, StellarStation, is a cloud-based ground station platform that enables satellite operators to establish communication links with their satellites using a diverse array of antennas worldwide. This platform allows ground station owners to monetize their excess capacity, facilitating efficient and cost-effective satellite communications. By improving transmission times and reducing costs, Infostellar empowers satellite operators to enhance the quality of their services and expand their business opportunities. The company's innovative approach contributes to the broader goal of advancing space communications infrastructure.

Accredify

Series A in 2021
Accredify is a Singapore-based company specializing in the creation and issuance of verifiable digital documents for organizations across various sectors. With a presence in over nine markets and a client base of 900 globally, Accredify has facilitated nearly 7 million verifications of its documents. The company's cloud-based system ensures that all issued documents are tamper-proof and traceable, allowing users to verify them through a simple drag-and-drop process. Initially focused on the higher education sector, Accredify has since expanded into healthcare, notably contributing to the development of Singapore's HealthCerts, which provide digitally verifiable COVID-19 test results. Recognized internationally, these certificates can be validated via QR codes and are accepted in over 32 countries. Accredify also offers a suite of APIs for seamless integration, enabling organizations to automate the issuance of verifiable digital credentials. With a commitment to customer service, security, and legal compliance, Accredify aims to be a trusted solution for document management and verification.

Allay Therapeutics

Series C in 2021
Allay Therapeutics is pioneering ultra-sustained pain therapeutics to transform post-surgical pain management. Its proprietary platform combines non-opioid analgesics and biopolymers to create dissolvable therapeutics delivering pain relief within targeted sites over weeks, significantly longer than current treatments. The company's lead product candidate, ATX101, is in Phase 2 clinical trials for total knee replacement surgeries.

Hydrogenious Technologies

Venture Round in 2021
Founded in 2013, Hydrogenious Technoloiges is a spin-off of the University of Erlangen-Nuremberg by its CEO Dr. Daniel Teichmann and the three co-founders Prof. Wolfgang Arlt, Prof. Peter Wasserscheid and Prof. Eberhardt Schlücker. The need for safe and efficient hydrogen storage for multi-MWh energy storage systems and safe and reliable hydrogen storage for hydrogen refuelling stations and fuel cell mobility was imminent – and Liquid Organic Hydrogen Carriers (LOHC) proved to be the solution. Having completed the technological proof of concept at the university’s laboratories, the idea became reality and Hydrogenious Technologies, a global pioneer in LOHC based energy storage, was born. With the University of Erlangen-Nuremberg becoming a shareholder in May 2014 and the successful close of a Series A funding round in July 2014 with Anglo American Platinum as investor, Hydrogenious Technologies is now backed with strong scientific, strategic and financial capacities to revolutionize large-scale energy and hydrogen storage.

Channel Talk

Series C in 2021
Channel Talk is an AI messenger that is focused on helping DTC companies provide VIP-level customer service. We raised $40 million USD in our Series C, and are one of the fastest-growing B2B SaaS startups, currently servicing more than 150,000 brands across the world. At Channel Talk, we believe that a good product nurtures growth in a business and that simple conversations with customers can become the driving force for success. We help you stand out by utilizing AI to resolve repetitive inquiries so you have time to build genuine relationships through our powerful CRM and provide excellent support to your customers.

Atama plus

Series B in 2021
Atama plus Inc. is an educational technology and SaaS startup based in Minato-ku, Tokyo, Japan, founded in 2017. The company specializes in providing AI-driven personalized learning programs for elementary, middle, and high school students. By analyzing various data points, including learning history, proficiency levels, concentration levels, and tendencies to forget, Atama plus designs adaptive learning experiences tailored to individual student needs. This approach aims to help students acquire fundamental academic skills efficiently while also fostering their ability to apply these skills in real-world contexts.

OY!

Series A in 2021
Founded in Jakarta in 2017 by Hilfi Alkaff, Jan Kristanto, and Jesayas Ferdinandus, OY! is a fintech company offering a user-friendly platform for managing finances. It facilitates free money transfers from debit cards, displays bank account balances and statements, and provides various financial products.

Standigm

Series D in 2021
Standigm, Inc. is a South Korean company founded in 2015 that specializes in artificial intelligence technologies for the pharmaceutical industry, focusing specifically on drug discovery. The company has developed proprietary AI platforms that streamline the drug development process, encompassing target identification, lead generation, and drug repurposing. Standigm's innovative workflow integrates advanced data parsing and biological interpretation to analyze biomedical data, allowing for the identification of valuable drug pipelines while minimizing traditional guesswork. Their automation technologies, including DarkMolFactory™, Standigm ASK™ for target discovery, and Standigm BEST™ for lead design, enable the rapid generation of First-in-Class lead compounds within a seven-month timeframe. By industrializing and automating the drug discovery process, Standigm aims to reduce both the time and cost associated with bringing new pharmaceuticals to market.

Insilico Medicine

Series C in 2021
Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

GrowSari

Series B in 2021
GrowSari is a technology-driven B2B platform designed to empower sari-sari stores by transforming them from basic fast-moving consumer goods (FMCG) outlets into comprehensive service hubs. The company provides shop owners with the necessary tools and infrastructure to digitally procure goods, thereby eliminating the need for middlemen. Through its e-commerce marketplace, GrowSari connects stores directly to suppliers, enabling owners to expand their product offerings to include mobile top-ups, remittances, and banking services. This approach not only helps store owners reduce costs but also enhances their understanding of market trends, ultimately benefiting grassroots communities across the nation.

KAHR medical

Venture Round in 2021
KAHR medical is a biopharmaceutical company developing fusion protein drugs for cancer and autoimmune disease treatment. Founded in 2005, it specializes in immuno-oncology, focusing on T-cell mediated tumor destruction and targeting CD47 tumors.

Net Protections

Corporate Round in 2021
Net Protections is a company that specializes in providing payment services, focusing on both business-to-consumer and business-to-business transactions. It operates several payment solutions, including "NP postpay," which caters to BtoC mail orders, and "NP payment" for B2B transactions. Additionally, the company offers "atone," a membership-based payment solution designed for consumers. With a strong emphasis on Buy Now Pay Later services, Net Protections aims to enhance the payment experience for both merchants and consumers, facilitating flexible payment options and improving overall transaction efficiency.

Super Studio

Funding Round in 2021
Super Studio specializes in providing Software as a Service (SaaS) solutions that enhance the efficiency of eco-friendly operations, sales processes, and customer experiences. They offer consulting services focused on product planning, development, manufacturing, sales promotion, supply chain optimization, customer relationship management, and enterprise collaboration platforms.

Inari

Series D in 2021
Inari is a biotechnology company focused on revolutionizing agriculture and its societal and environmental impact. The company utilizes advanced technologies, including predictive design and multiplex gene editing, to maximize the potential of seeds. Its unique SEEDesign platform distinguishes Inari by enabling the enhancement of various crops across different geographies, facilitating the development of innovative agricultural products. By embracing diversity, Inari fosters innovation and aims to contribute to the creation of a new food system.

Blind

Series C in 2021
Blind is an anonymous professional network designed to facilitate open communication among verified professionals across various industries. With over 4.1 million users worldwide, the platform enables individuals to engage in private company channels with colleagues and participate in open forums for broader discussions. Users can share valuable insights, such as job offer details and honest feedback about company culture, without fear of judgment or retribution. Blind aims to promote transparency in the workplace, empowering professionals to make informed decisions and encouraging meaningful change within their organizations.

Innogen Pharmaceutical

Venture Round in 2021
Innogen Pharmaceutical Technology is an international biopharmaceutical company specializing in the development and manufacturing of innovative drugs. The company utilizes advanced genetic engineering and recombinant protein biopharmaceutical processes to create new therapies. Its primary focus is on addressing the treatment needs of patients suffering from diabetic metabolic diseases and significant central nervous system disorders. Through its research and development efforts, Innogen aims to deliver effective solutions that enhance patient care and improve health outcomes.

NEON

Private Equity Round in 2021
NEON is a global leader specializing in creating and producing immersive experiences. It partners with renowned brands like Disney, Marvel, NBCUniversal, and Warner Bros., as well as governments for original artifact exhibitions. NEON has brought compelling experiences to millions of visitors across over 60 cities worldwide.

Korea Credit Data

Series C in 2021
Korea Credit Data Co., Ltd. is a Seoul-based company that specializes in developing business management software, particularly for small and medium enterprises. Founded in 2016, its flagship product, CashNote, enables users to manage card payment schedules, conduct customer analysis, and perform tax invoice inquiries. In addition to CashNote, Korea Credit Data offers a range of services that include customer analysis, point-of-sale (POS) systems, and payment solutions through its various subsidiaries. The company serves over two million businesses in Korea, aiming to address challenges faced by business owners throughout their operational lifecycle. By forming strategic partnerships with leading industry players, Korea Credit Data has established a strong market presence and expanded its offerings to include payment networks and credit bureau services, enhancing its ability to support its clients effectively.

Studist

Seed Round in 2021
Studist develops the Teachme Biz platform, enabling businesses to create and share standard operating procedure manuals using images and videos. Its mission is to minimize information loss during transmission within companies.

Catallaxy

Series A in 2021
Catallaxy is a platform and services company that provides metal parts procurement, cloud business management, and consulting. It operates Mitsuri, a trading platform for web quotes of metal custom parts linked to suppliers, including processing for industrial machinery, factory automation equipment, and facility equipment, and it also runs Fabit, a platform for manufacturing media. The company coordinates with processing companies and partner factories to streamline procurement, production, and distribution of metal parts, enabling customers to receive materials and improve operational efficiency.

Duckbill

Venture Round in 2021
Duckbill provides container trucking transportation services, international freight forwarding, and warehousing services by using big data and AI.

Sicepat Express

Series B in 2021
PT. SiCepat Ekspres Indonesia is a logistics company established in 2004 and headquartered in Jakarta Pusat, Indonesia. The company specializes in courier delivery services throughout Indonesia, providing a range of logistics and shipping solutions. Its offerings include freight forwarding, warehousing, parcel courier, consignment, and delivery services. SiCepat Ekspres aims to facilitate trade in emerging markets by ensuring the timely movement of shipments, thereby supporting businesses in their growth and operational efficiency.

Zilliz

Series B in 2020
Founded in 2016, Zilliz specializes in developing advanced vector database technologies. Headquartered in San Francisco, the company empowers organizations worldwide to create AI/ML applications by simplifying complex data infrastructure management.

Waresix

Series B in 2020
Waresix is a logistics platform headquartered in Jakarta, Indonesia. It connects businesses with unused warehouse space, enabling dynamic warehousing strategies that adapt to fluctuating demand.

Sociolla

Series E in 2020
Sociolla is an Indonesian online retailer specializing in beauty and personal care products. It offers a wide range of makeup, skincare, haircare, beauty equipment, and perfume, sourced directly from authorized distributors to ensure product authenticity.

Everest Medicines

Series C in 2020
Everest Medicines is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapies for critical unmet medical needs, initially focusing on Asia Pacific markets.

Doctor Anywhere

Series B in 2020
Doctor Anywhere is a Singapore-based telehealth company that provides on-demand healthcare solutions. Its digital platform offers quick access to health and wellness services, optimized for convenient lifestyle management.

KAHR medical

Series D in 2020
KAHR medical is a biopharmaceutical company developing fusion protein drugs for cancer and autoimmune disease treatment. Founded in 2005, it specializes in immuno-oncology, focusing on T-cell mediated tumor destruction and targeting CD47 tumors.

GudangAda

Seed Round in 2020
GudangAda is a developer of a business-to-business (B2B) marketplace focused on transforming and digitalizing Indonesia's distribution chain for fast-moving consumer goods. The company connects key stakeholders, including principals, distributors, wholesalers, and retailers, through an end-to-end digital solution. Its platform allows users to meet and conduct transactions online, supporting both small and bulk orders. By facilitating these transactions, GudangAda enables traders to operate as both sellers and buyers simultaneously, which enhances turnover, reduces costs, and expands customer reach. The company also offers logistics, merchant solutions, and financial services, contributing to the efficiency and effectiveness of the supply chain within the marketplace.

OY!

Seed Round in 2020
Founded in Jakarta in 2017 by Hilfi Alkaff, Jan Kristanto, and Jesayas Ferdinandus, OY! is a fintech company offering a user-friendly platform for managing finances. It facilitates free money transfers from debit cards, displays bank account balances and statements, and provides various financial products.

Appier

Series D in 2019
Appier Inc., established in 2012 and headquartered in Taipei, Taiwan, specializes in providing AI-powered platforms for enterprises worldwide. Its suite of products includes Aideal for driving purchase decisions, AIQUA for proactive customer engagement, AIXON for unified data science, and CrossX for AI-driven advertising solutions. Appier serves approximately 1,000 global brands and agencies across Asia from its offices in 14 markets, helping businesses make data-driven decisions to increase customer engagement and predict user behavior without the need for specialized AI engineers.

Travelio

Series B in 2019
Travelio is an online marketplace for short-term home rentals, offering a diverse range of accommodations, including apartments, villas, and houses. Founded on March 24, 2015, by Christine Amanda, Christina Suriadjaja, and Hendry Rusli, the platform simplifies the property rental process for both renters and property owners. It enables clients to easily reserve and select their desired accommodations online while providing property owners and developers with tools to lease and manage their vacant properties effectively. Travelio aims to enhance the rental experience by connecting travelers with suitable housing options.

NEON

Private Equity Round in 2019
NEON is a global leader specializing in creating and producing immersive experiences. It partners with renowned brands like Disney, Marvel, NBCUniversal, and Warner Bros., as well as governments for original artifact exhibitions. NEON has brought compelling experiences to millions of visitors across over 60 cities worldwide.

Nuvation Bio

Series A in 2019
Nuvation Bio is a global biopharmaceutical company dedicated to developing innovative therapies for oncology, focusing on patients with difficult-to-treat cancers where conventional treatments have proven ineffective.

Structo

Series D in 2019
Structo is a digital manufacturing platform specializing in dental 3D printing services. The company has developed a range of application-specific 3D printing resins that complement its proprietary hardware technology. By focusing on enhancing the speed and efficiency of 3D printing, Structo enables users to achieve higher throughput at lower costs compared to traditional stereolithography (SLA) printers. Their innovative approach allows dental professionals to revolutionize their business models while maintaining high print quality.

Advance Intelligence Group

Series C in 2019
Advance Intelligence Group is a financial technology firm that builds an ecosystem of AI-powered, credit-enabled products, and services. Founded in 2016, it leverages innovative technology and partnerships to build an ecosystem of products and services serving consumers, enterprises, and merchants.

Insilico Medicine

Series B in 2019
Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

CyCraft

Series B in 2019
CyCraft is a cybersecurity company that serves governments, financial institutions, manufacturing, and other organizations with an AI-powered platform, CyCraft AIR. The platform provides endpoint detection and response, network detection and response, operational global threat intelligence, and enterprise cyber-health checks. CyCraft emphasizes autonomous systems and human-AI collaboration to strengthen cyber resilience and aims to deliver ROI-efficient resilience solutions on a global scale.

Fore Coffee

Series A in 2019
Fore Coffee is a Jakarta-based specialty coffee company founded in 2018 that operates a network of coffee outlets. It positions itself as a technology-enabled coffee joint that brews each cup with freshly roasted Arabica beans and an espresso blend designed to deliver a strong, flavorful coffee. The company emphasizes premium products and packaging, and its outlets are designed with a comfortable, aesthetically focused concept to enhance the customer experience.

Warung Pintar

Series A in 2019
Warung Pintar is a micro retail technology company in Indonesia that aims to digitalize commerce for underserved communities. It uses data processing and analytics to capture insights from the bottom of the pyramid to support financial inclusion, social security, behavior analysis, and community engagement, with impact monitoring. The company also provides an end-to-end business platform for small retailers, featuring supply chain digitization, integrated applications, financial services, data analytics, and e-commerce tools to help manage inventory and resources more efficiently.

17Live

Venture Round in 2018
17LIVE Inc. is a live streaming platform that operates primarily in Taiwan, Japan, South Korea, Singapore, and Hong Kong. Founded in 2015 and headquartered in New Taipei City, Taiwan, the company offers its live streaming services under the 17 Media brand. Additionally, it provides online dating services through its Paktor and Goodnight brands. The platform enables users to share their life experiences and talents in real-time, fostering social connections and community engagement. 17LIVE aims to facilitate instant audio and video communication, allowing users to connect with others globally, regardless of their location. The company, which was formerly known as M17 Entertainment Limited, rebranded to 17LIVE Inc. in October 2020.

Airobotics

Series D in 2018
Airobotics is a manufacturer of autonomous unmanned aerial drones that offers a comprehensive, fully automated solution for collecting aerial data and generating insights. The company serves various sectors, including government, industrial, and commercial industries. Airobotics specializes in automated data capture and analysis, providing services such as real-time video, disaster and scene assessment, compliance audits, land investigations, inspections, surveillance, progress monitoring, and survey services. By leveraging advanced drone technology, Airobotics enables organizations to efficiently gather critical data and make informed decisions.

Warung Pintar

Seed Round in 2018
Warung Pintar is a micro retail technology company in Indonesia that aims to digitalize commerce for underserved communities. It uses data processing and analytics to capture insights from the bottom of the pyramid to support financial inclusion, social security, behavior analysis, and community engagement, with impact monitoring. The company also provides an end-to-end business platform for small retailers, featuring supply chain digitization, integrated applications, financial services, data analytics, and e-commerce tools to help manage inventory and resources more efficiently.

Insilico Medicine

Series A in 2018
Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

Orchard Therapeutics

Series B in 2017
Orchard Therapeutics is a UK-based biopharmaceutical company dedicated to developing and commercializing innovative gene therapies for rare diseases. Its core focus is autologous ex vivo gene therapy, transforming hematopoietic stem cells into a gene-modified drug product for single-administration treatments. The company's portfolio includes Strimvelis, approved by the EMA in 2016, and several programs in advanced registrational studies across various disease areas.

Appier

Series B in 2016
Appier Inc., established in 2012 and headquartered in Taipei, Taiwan, specializes in providing AI-powered platforms for enterprises worldwide. Its suite of products includes Aideal for driving purchase decisions, AIQUA for proactive customer engagement, AIXON for unified data science, and CrossX for AI-driven advertising solutions. Appier serves approximately 1,000 global brands and agencies across Asia from its offices in 14 markets, helping businesses make data-driven decisions to increase customer engagement and predict user behavior without the need for specialized AI engineers.

SORACOM

Series B in 2016
SORACOM is a Tokyo-based company that specializes in providing an Internet of Things (IoT) platform designed to facilitate data communication for IoT and M2M (machine-to-machine) devices. The platform leverages scalable cloud technologies running on Amazon Web Services, enabling IoT solution developers to efficiently deploy and enhance their services while accommodating a variety of needs through flexible and customizable options. SORACOM enhances the security and reliability of data transfer across numerous devices and custom protocols, significantly reducing both time-to-market and costs associated with IoT services. Key offerings include SORACOM Air, which provides mobile data communication for IoT devices through its "Air SIM," allowing users to manage settings and monitor data traffic via a web console or API. Additionally, SORACOM Beam enables secure offloading of data from IoT devices to the cloud, ensuring high encryption and remote management capabilities without direct Internet exposure. Since its official launch in September 2015, SORACOM has positioned itself as a comprehensive provider of IoT solutions.

TMON

Private Equity Round in 2015
Ticket Monster Inc. is an e-commerce company in Korea today. In 2014, 70% of TMON’s transactions were completed on mobile devices and its customer base continued to expand into multiple age segments. The company operates in three key verticals - Goods, Local and Travel - and offers over 47,000 SKUs through partnerships with approximately 15,000 merchants.

Star 360 Holdings

Private Equity Round in 2014
Star 360 Holdings is a Singapore-based retailer specializing in sports and fashion footwear. The company offers a diverse range of products, including casual and formal footwear for men and women, running shoes, sandals, sneakers, and sports-specific shoes. In addition to footwear, Star 360 provides various accessories such as bags, wallets, and gym essentials like hydration products and masks. The company operates specialty stores and distributes its products globally, ensuring that customers have access to a wide selection of world-class brands tailored to their preferences.

Jianpu Technology

Series C in 2014
Jianpu Technology Inc. is the independent open platform for discovery and recommendation of financial products in China, according to the iResearch Report*. By leveraging our deep data insights and proprietary technology, we provide users with personalized search results and recommendations that are tailored to each user’s particular financial needs and credit profile. We also enable financial service providers with sales and marketing solutions to reach and serve their target customers more effectively through online and mobile channels, and enhance their competitiveness by providing them with tailored data, risk management and end-to-end solutions. We are committed to maintaining an independent open platform, which allows us to serve the needs of users and financial service providers impartially.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.